Urologie pro praxi 4/2025
The significance of the systematic component in MR/TRUS fusion biopsy for prostate diagnosis: a retrospective study
Worldwide, prostate cancer is among the most significant malignancies in the male population. It is a serious health issue that requires ongoing improvements of diagnostic methods and treatment strategies. Effective and accurate diagnosis, especially of clinically significant prostate cancers, plays a key role in the entire management of this disease, treatment planning and improving both patient the quality of life and survival of patients. This article presents our experiences with the fusion biopsy program and its potential use in clinical practice. The primary aim of this retrospective study was to determine whether it is necessary to perform systematic components of fusion biopsies. We compared cancer detection rates in targeted lesions and those discovered randomly, as well as their grading and correlation with radiological classification.
Keywords: urological oncology, prostate cancer, diagnostic evaluation, magnetic resonance, imaging‑ultrasound fusion targeted biopsy.
